Refoxy Pharmaceuticals GmbH
refoxy.com
Actively hiring
Cardiometabolic Therapeutics
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
2
High-Tech Gründerfonds, NRW.BANK
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
| Legal entity | Refoxy Pharmaceuticals GmbH | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds 
NRW.BANK Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…
MitoRx is developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity.
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cologne
Germany
HQ
10-50 est. staff